ATE377429T1 - Anwendung von pdt zur inhibierung von hyperplasie der intima - Google Patents

Anwendung von pdt zur inhibierung von hyperplasie der intima

Info

Publication number
ATE377429T1
ATE377429T1 AT00979292T AT00979292T ATE377429T1 AT E377429 T1 ATE377429 T1 AT E377429T1 AT 00979292 T AT00979292 T AT 00979292T AT 00979292 T AT00979292 T AT 00979292T AT E377429 T1 ATE377429 T1 AT E377429T1
Authority
AT
Austria
Prior art keywords
pdt
intimal hyperplasia
inhibit intimal
inhibit
present
Prior art date
Application number
AT00979292T
Other languages
English (en)
Inventor
Beth Allison
Philippe Margaron
York Hsiang
Original Assignee
Quadra Logic Tech Inc
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Univ British Columbia filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE377429T1 publication Critical patent/ATE377429T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Physical Vapour Deposition (AREA)
AT00979292T 1999-11-17 2000-11-17 Anwendung von pdt zur inhibierung von hyperplasie der intima ATE377429T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16593999P 1999-11-17 1999-11-17

Publications (1)

Publication Number Publication Date
ATE377429T1 true ATE377429T1 (de) 2007-11-15

Family

ID=22601107

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00979292T ATE377429T1 (de) 1999-11-17 2000-11-17 Anwendung von pdt zur inhibierung von hyperplasie der intima

Country Status (6)

Country Link
EP (1) EP1229937B1 (de)
AT (1) ATE377429T1 (de)
AU (2) AU1617001A (de)
CA (1) CA2391389A1 (de)
DE (1) DE60037032T2 (de)
WO (2) WO2001035997A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6520981B1 (en) 1999-10-01 2003-02-18 The General Hospital Corporation Significance of dosimetry in photodynamic therapy of injured arteries
US7753943B2 (en) 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
US6800086B2 (en) 2001-02-06 2004-10-05 Qlt Inc. Reduced fluence rate PDT
US6887862B2 (en) 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
JP2004532251A (ja) * 2001-05-31 2004-10-21 ミラヴァント ファーマシューティカルズ インコーポレイテッド 光線力学療法で使用のメタロテトラピロール系光増感剤
US7223282B1 (en) 2001-09-27 2007-05-29 Advanced Cardiovascular Systems, Inc. Remote activation of an implantable device
US6783541B2 (en) 2001-11-21 2004-08-31 Miravant Medical Technologies, Inc. Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
WO2009003173A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodymanic therapy
US10549112B2 (en) 2012-07-20 2020-02-04 The General Hospital Corporation Apparatus for tissue irradiation and methods and kits utilizing the same
WO2014015274A1 (en) 2012-07-20 2014-01-23 The General Hospital Corporation Methods for tissue passivation
CA2918539C (en) * 2013-07-18 2025-11-18 The General Hospital Corporation ANATOMICAL VESSEL PROCESSING SYSTEMS, METHODS AND ASSOCIATED KITS
CN111760036B (zh) * 2020-06-11 2021-12-14 浙江大学 一种基于锰基的肿瘤诊疗一体化纳米材料、制备方法和应用
CN115920139B (zh) * 2022-11-25 2024-07-02 杭州矩正医疗科技有限公司 一种光动力球囊导管系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
US6364907B1 (en) * 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6520981B1 (en) * 1999-10-01 2003-02-18 The General Hospital Corporation Significance of dosimetry in photodynamic therapy of injured arteries

Also Published As

Publication number Publication date
WO2001035997A2 (en) 2001-05-25
CA2391389A1 (en) 2001-05-25
DE60037032T2 (de) 2008-07-10
WO2001035997A3 (en) 2002-06-13
EP1229937B1 (de) 2007-11-07
AU1617001A (en) 2001-05-30
DE60037032D1 (de) 2007-12-20
AU1683901A (en) 2001-05-30
WO2001035996A3 (en) 2002-01-03
EP1229937A2 (de) 2002-08-14
WO2001035996A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
DE60037032D1 (de) Anwendung von pdt zur inhibierung von hyperplasie der intima
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
BR0107705A (pt) Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva
PL334565A1 (en) Phototherapeutic compositions
WO2002096366A3 (en) Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
DK1003553T3 (da) Anvendelsen af angiostatiske steroider i fotodynamisk terapi
NO995776D0 (no) Fremgangsmåte for behandling av trombosesykdommer
NO20013064D0 (no) Kombinasjonsterapi med bestråling og en cox-2-inhibitor ved behandling av neoplasia
ATE198706T1 (de) Polyamin-verbindungen zur behandlung von proliferativer erkrankungen
BR9913564A (pt) Tratamento de angiopatias microvasculares
DE69841041D1 (de) Stent beschichtet mit dna
WO2001024825A3 (en) Significance of dosimetry in photodynamic therapy of injured arteries
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
DE60237607D1 (de) Verwendung von magnesium zur verhinderung der in-stent thrombose und komplikationen nach gefässinterner arterioplastik mit stent einführung
PT971710E (pt) Utilizacao de queleritrina e radiacao para terapia de tumores
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
DE60318561D1 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie
GB9723824D0 (en) Cytostatic agents
WO2001089489A3 (de) Transdermale applikation von wirkstoffen direkt über der halsschlagader
DK1463541T3 (da) Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer
UA31754A (uk) Спосіб профілактики рецидивів меланоми шкіри
UA29648A (uk) Спосіб лікування хімічних опіків стравоходу

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties